ADIPOQ and Insulin resistance: Koistinen et al. evaluated insulin resistance and adiponectin levels in patients prior to treatment, at the 5th month of treatment, and 1 month after termination of treatment, and similar to our study, they found a 34% increase in adiponectin levels compared with the decrease in insulin sensitivity in patients during treatment.